4006-776-356 出国就医服务电话

免费获得国外相关药品,最快 1 个工作日回馈药物信息

出境医 / 临床实验 / Pre- and Post-operative Brain MRI in Carotid Endarterectomy

Pre- and Post-operative Brain MRI in Carotid Endarterectomy

Study Description
Brief Summary:
Patients undergoing carotid endarterectomy in the Department of Vascular Surgery at Oslo University Hospital are consecutively included in this evaluation og pre- and postoperative brain MRI.

Condition or disease Intervention/treatment
Carotid Artery Stenoses Diagnostic Test: Brain MRI

Detailed Description:
Patients undergoing surgery for carotid stenosis in our Department are examined by brain MRI before and after carotid surgery to evaluate the rationale for the MRI. Brain lesions on MRI before and after carotid surgery are registered, and related to clinical findings. The purpose of the study is to evaluate whether brain MRI in relation to carotid endarterectomy gives additional information to clinical findings, and to CT scan of the brain.
Study Design
Layout table for study information
Study Type : Observational
Actual Enrollment : 320 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Evaluation of Pre- and Post-operative Brain MRI in Carotid Endarterectomy
Actual Study Start Date : January 1, 2005
Actual Primary Completion Date : December 31, 2016
Actual Study Completion Date : December 31, 2017
Arms and Interventions
Outcome Measures
Primary Outcome Measures :
  1. Brain lesions on MRI [ Time Frame: 30 days ]
    Lesions on brain MRI representing thromboembolic or hemorrhagic episodes


Secondary Outcome Measures :
  1. Time from Transient Ischemic Attack (TIA) or minor stroke to surgery [ Time Frame: Days before surgery, maximum 6 months ]
    International guidelines recommends surgery within 14 days after TIA


Other Outcome Measures:
  1. Complications to carotid surgery [ Time Frame: Within 30 days after surgery ]
    TIA, minor stroke, nerve damage


Eligibility Criteria
Contacts and Locations
Tracking Information
First Submitted Date August 3, 2017
First Posted Date July 23, 2019
Last Update Posted Date July 23, 2019
Actual Study Start Date January 1, 2005
Actual Primary Completion Date December 31, 2016   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures
 (submitted: July 21, 2019)
Brain lesions on MRI [ Time Frame: 30 days ]
Lesions on brain MRI representing thromboembolic or hemorrhagic episodes
Original Primary Outcome Measures Same as current
Change History No Changes Posted
Current Secondary Outcome Measures
 (submitted: July 21, 2019)
Time from Transient Ischemic Attack (TIA) or minor stroke to surgery [ Time Frame: Days before surgery, maximum 6 months ]
International guidelines recommends surgery within 14 days after TIA
Original Secondary Outcome Measures Same as current
Current Other Pre-specified Outcome Measures
 (submitted: July 21, 2019)
Complications to carotid surgery [ Time Frame: Within 30 days after surgery ]
TIA, minor stroke, nerve damage
Original Other Pre-specified Outcome Measures Same as current
 
Descriptive Information
Brief Title Pre- and Post-operative Brain MRI in Carotid Endarterectomy
Official Title Evaluation of Pre- and Post-operative Brain MRI in Carotid Endarterectomy
Brief Summary Patients undergoing carotid endarterectomy in the Department of Vascular Surgery at Oslo University Hospital are consecutively included in this evaluation og pre- and postoperative brain MRI.
Detailed Description Patients undergoing surgery for carotid stenosis in our Department are examined by brain MRI before and after carotid surgery to evaluate the rationale for the MRI. Brain lesions on MRI before and after carotid surgery are registered, and related to clinical findings. The purpose of the study is to evaluate whether brain MRI in relation to carotid endarterectomy gives additional information to clinical findings, and to CT scan of the brain.
Study Type Observational
Study Design Observational Model: Cohort
Time Perspective: Prospective
Target Follow-Up Duration Not Provided
Biospecimen Not Provided
Sampling Method Non-Probability Sample
Study Population Patients referred to the Department of Vascular Surgery at Oslo University Hospital for carotid endarterectomy. International guidelines on indications for surgery are followed, and the majority of the patients have symptomatic carotid stenosis occluding > 70% of the lumen of the internal carotid artery. Patients characteristics and indications for surgery are registered
Condition Carotid Artery Stenoses
Intervention Diagnostic Test: Brain MRI
Brain MRI diagnoses tromboembolic lesions or bleeding to the cerebrum and is part of preoperative diagnostic tests before carotid surgery. After surgery brain MRI may present New lesions related to surgery, clinically significant or insignificant. Our goal is to evaluate the relevance of this modality in carotid surgery..
Study Groups/Cohorts Not Provided
Publications * Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status Completed
Actual Enrollment
 (submitted: July 21, 2019)
320
Original Actual Enrollment Same as current
Actual Study Completion Date December 31, 2017
Actual Primary Completion Date December 31, 2016   (Final data collection date for primary outcome measure)
Eligibility Criteria

Inclusion Criteria:

  • Indication for carotid surgery

Exclusion Criteria:

  • Contraindications to MRI
Sex/Gender
Sexes Eligible for Study: All
Ages Child, Adult, Older Adult
Accepts Healthy Volunteers No
Contacts Contact information is only displayed when the study is recruiting subjects
Listed Location Countries Not Provided
Removed Location Countries  
 
Administrative Information
NCT Number NCT04029259
Other Study ID Numbers MR caput and CEA
Has Data Monitoring Committee No
U.S. FDA-regulated Product
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
IPD Sharing Statement
Plan to Share IPD: Undecided
Plan Description: No plan
Responsible Party Toril Rabben, Oslo University Hospital
Study Sponsor Oslo University Hospital
Collaborators Not Provided
Investigators
Principal Investigator: Toril Rabben, PhD Oslo University Hospital, Dep. of Vascular Surgery
PRS Account Oslo University Hospital
Verification Date July 2019